Evolving approaches on measurements and applications of intracellular free drug concentration and Kp_uu in drug discovery

References

• Smith DA, Di L, Kerns EH. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov. 2010;9(12):929–939.
   PubMed Web of Science ®Google Scholar
• Scott DO, Ghosh A, Di L, et al. Passive Drug Permeation through Membranes and Cellular Distribution. Pharmcological Research. 2017;117:94–102.
   Google Scholar
• Riccardi K, Li Z, Brown Janice A, et al. Determination of Unbound Partition Coefficient and in Vitro-in Vivo Extrapolation for SLC13A Transporter-Mediated Uptake. Drug Metab Dispos. 2016;44(10):1633–1642.
   PubMed Web of Science ®Google Scholar
• Orozco CC, Atkinson K, Ryu S, et al. Structural attributes influencing unbound tissue distribution. Eur J Med Chem. 2020;185:111813.
   PubMed Web of Science ®Google Scholar
• Riccardi K, Lin J, Li Z, et al. Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes. Drug Metab Dispos. 2017;45(5):576–580.
   PubMed Web of Science ®Google Scholar
• Assmus F, Houston JB, Galetin A. Incorporation of lysosomal sequestration in the mechanistic model for prediction of tissue distribution of basic drugs. Eur J Pharm Sci. 2017;109:419–430.
   PubMed Web of Science ®Google Scholar
• Blouin A, Bolender RP, Weibel ER. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. Journal of Cell Biology. 1977;72(2):441–455.
   PubMed Web of Science ®Google Scholar
• Naim B, Brumfeld V, Kapon R, et al. Passive and Facilitated Transport in Nuclear Pore Complexes Is Largely Uncoupled. Journal of Biological Chemistry. 2007;282(6):3881–3888.
   PubMed Web of Science ®Google Scholar
• Timney BL, Raveh B, Mironska R, et al. Simple rules for passive diffusion through the nuclear pore complex. J. Cell Biol. 2016;215(1):57–76.
   PubMed Web of Science ®Google Scholar
• Gilmore IS, Heiles S, Pieterse CL. Metabolic Imaging at the Single-Cell Scale: recent Advances in Mass Spectrometry Imaging. Annu. Rev. Anal. Chem. 2019;12(1):201–224.
   PubMedGoogle Scholar
• Sepp K, Lee M, Bluntzer MTJ, et al. Utilizing Stimulated Raman Scattering Microscopy To Study Intracellular Distribution of Label-Free Ponatinib in Live Cells. J Med Chem. 2020;63(5):2028–2034.
   PubMed Web of Science ®Google Scholar
• El-Mashtoly SF. Drug Distribution in Living Cells via Label-Free Molecular Fingerprint. J Med Chem. 2020;63(7):3472–3474.
   PubMed Web of Science ®Google Scholar
• Elgart V, Lin J-R, Loscalzo J. Determinants of drug-target interactions at the single cell level. PLOS Computational Biology. 2018, 14, e1006601/1-e1006601/23.(12):e1006601.
   PubMed Web of Science ®Google Scholar
• Riccardi K, Ryu S, Lin J, et al. Comparison of species and cell-type differences in fraction unbound of liver tissues, hepatocytes, and cell lines. Drug Metab Dispos. 2018;46(4):415–S4.
   PubMed Web of Science ®Google Scholar
• Riccardi K, Ryu S, Tess D, et al. Comparison of Fraction Unbound Between Liver Homogenate and Hepatocytes at 4°C. AAPS J. 2020;22(4):91.
   PubMed Web of Science ®Google Scholar
• Yoshikado T, Toshimoto K, Nakada T, et al. Comparison of methods for estimating unbound intracellular-to-medium concentration ratios in rat and human hepatocytes using statins. Drug Metab Dispos. 2017;45(7):779–789.
   PubMed Web of Science ®Google Scholar
• Shitara Y, Maeda K, Ikejiri K, et al. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. Biopharm Drug Dispos. 2013;34(1):45–78.
   PubMed Web of Science ®Google Scholar
• Izumi S, Nozaki Y, Komori T, et al. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro–In Vivo Extrapolation Approaches. J Pharm Sci. 2017;106(9):2678–2687.
   PubMed Web of Science ®Google Scholar
• Trunkle C, Lechner C, Korr D, et al. Concentration Dependence of the Unbound Partition Coefficient Kpuu and Its Application to Correct for Exposure-Related Discrepancies between Biochemical and Cellular Potency of KAT6A Inhibitors. Drug Metab Dispos. 2020;48(7):553–562.
   PubMed Web of Science ®Google Scholar
• Yabe Y, Galetin A, Houston JB. Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos. 2011; 39(10):1808-1814.
   PubMed Web of Science ®Google Scholar
• Ryu S, Tess D, Chang G, et al. Evaluation of Fraction Unbound Across 7 Tissues of 5 Species. J. Pharm. Sci. 2020;109:1178–1190.
   PubMed Web of Science ®Google Scholar
• Ryu S, Riccardi K, Jordan S, et al. Determination of Fraction Unbound and Unbound Partition Coefficient to Estimate Intracellular Free Drug Concentration. In: Rosania GR, Thurber GM, editors. Quantitative Analysis of Cellular Drug Transport, Disposition, and Delivery, Methods in Pharmacology and Toxicology. Springer, New York, NY; 2021;81–96.
   Google Scholar
• Riccardi KA, Tess DA, Lin J, et al. A novel unified approach to predict human hepatic clearance for both enzyme- and transporter-mediated mechanisms using suspended human hepatocytes. Drug Metab Dispos. 2019;47(5):484–492.
   PubMed Web of Science ®Google Scholar
• Riede J, Camenisch G, Huwyler J, et al. Current In Vitro Methods to Determine Hepatic Kp uu : a Comparison of Their Usefulness and Limitations. J Pharm Sci. 2017;106(9):2805–2814.
   PubMed Web of Science ®Google Scholar
• Ryu S, Novak JJ, Patel R, et al. The impact of low temperature on fraction unbound for plasma and tissue. Biopharmaceutics & Drug Disposition. 2018;39(9):437–442.
   PubMed Web of Science ®Google Scholar
• Faneyte IF, Kristel PMP, Van De Vijver MJ. DeterminingMDR1/P-glycoprotein expression in breast cancer. International Journal of Cancer. 2001;93(1):114–122.
   PubMed Web of Science ®Google Scholar
• Lemos C, Kathmann I, Giovannetti E, et al. Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins. Molecular Cancer Therapeutics. 2009;8(3):655–664.
   PubMed Web of Science ®Google Scholar
• Oba T, Izumi H, Ito K-I. ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines. Oncotarget. 2016;7(43):70011–70027.
   PubMedGoogle Scholar
• Di L, Breen C, Chambers R, et al. Industry Perspective on Contemporary Protein-Binding Methodologies: considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs. J. Pharm. Sci. (Philadelphia, PA, U. S.). 2017;106:3442–3452.
   PubMed Web of Science ®Google Scholar
• Riccardi K, Cawley S, Yates PD, et al. Plasma Protein Binding of Challenging Compounds. J Pharm Sci. 2015;104(8):2627–2636.
   PubMed Web of Science ®Google Scholar
• Li Z, Erion D, Maurer T. Model-Based Assessment of Plasma Citrate Flux Into the Liver: implications for NaCT as a Therapeutic Target. CPT: pharmacometrics & systems pharmacology. 2016;5(3):132–139.
   PubMedGoogle Scholar
• Huard K, Gosset JR, Montgomery JI, et al. Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family. J Med Chem. 2016;59(3):1165–1175.
   PubMed Web of Science ®Google Scholar
• Lee KK, Workman JL. Histone acetyltransferase complexes: one size doesn’t fit all. . Nature Reviews Molecular Cell Biology. 2007;8(4):284–295.
   PubMed Web of Science ®Google Scholar
• Baell JB, Leaver DJ, Hermans SJ, et al. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. Nature (London, U. K.). 2018;560(7717):253–257.
   PubMed Web of Science ®Google Scholar
• Arthur JSC, Ley SC. Mitogen-activated protein kinases in innate immunity. . Nature Reviews Immunology. 2013;13(9):679–692.
   PubMed Web of Science ®Google Scholar
• Mateus A, Gordon LJ, Wayne GJ, et al. Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery. Proceedings of the National Academy of Sciences. 2017;114(30): E6231–E6239.
   PubMed Web of Science ®Google Scholar
• Albermann N, Schmitz-Winnenthal FH, Z’Graggen K, et al. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochemical Pharmacology. 2005;70(6):949–958.
   PubMed Web of Science ®Google Scholar
• Shola AI, Adegboye A. Polypharmacy in the elderly: the need for concern and strategies for its control. British Journal of Pharmaceutical Research. 2015;8(5):1–12.
   Google Scholar
• Lu C, Di L. In vitro and in vivo methods to assess pharmacokinetic drug– drug interactions in drug discovery and development. Biopharmaceutics & Drug Disposition. 2020;41(1–2):3–31.
   PubMed Web of Science ®Google Scholar
• Saravanakumar A, Sadighi A, Ryu R, et al. Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: a Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016. Clinical Pharmacokinetics. 2019;58(10):1281–1294.
   PubMed Web of Science ®Google Scholar
• Treyer A, Ullah M, Parrott N, et al. Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies. AAPS J. 2019;21(5):77.
   PubMed Web of Science ®Google Scholar
• Filppula AM, Parvizi R, Mateus A, et al. Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations. Scientific Reports. 2019;9(1): 1–14.
   PubMedGoogle Scholar
• Di L, Whitney‐Pickett C, Umland JP, et al. Development of a new permeability assay using low-efflux MDCKII cells. J Pharm Sci. 2011;100(11):4974–4985.
   PubMed Web of Science ®Google Scholar
• Keefer C, Chang G, Carlo A, et al. Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes. Eur J Pharm Sci. 2020;155:105541.
   PubMed Web of Science ®Google Scholar
• Di L, Keefer C, Scott DO, et al. Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug design. Eur J Med Chem. 2012;57:441–448.
   PubMed Web of Science ®Google Scholar
• Li M, Yuan H, Li N, et al. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Eur J Pharm Sci. 2008;35(1–2):114–126.
   PubMed Web of Science ®Google Scholar
• Billington S, Shoner S, Lee S, et al. Positron Emission Tomography Imaging of [11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A. Clinical Pharmacology & Therapeutics. 2019;106(5):1056–1066.
   PubMed Web of Science ®Google Scholar
• Gormsen LC, Sundelin EI, Jensen JB, et al. In vivo imaging of human 11C-metformin in peripheral organs: dosimetry, biodistribution, and kinetic analyses. J Nucl Med. 2016;57(12):1920–1926.
   Google Scholar
• Kaneko K-I, Tanaka M, Ishii A, et al. A Clinical Quantitative Evaluation of Hepatobiliary Transport of [11 C]Dehydropravastatin in Humans Using Positron Emission Tomography. Drug Metab Dispos. 2018;46(5):719–728.
   PubMed Web of Science ®Google Scholar
• Li Z, Di TS, Maurer TS. Theoretical Considerations for Direct Translation of Unbound Liver-to-Plasma Partition Coefficient from In Vitro to In Vivo. AAPS J. 2019;21(3):43.
   PubMed Web of Science ®Google Scholar
• Bowman CM, Benet LZ. An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation. Eur J Pharm Sci. 2018;123:502–514.
   PubMed Web of Science ®Google Scholar
• Poulin P, Haddad S. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: comparative Assessment of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights. J. Pharm. Sci.2018;107(7):1791–1797.
   Google Scholar
• Miyauchi S, Masuda M, Kim S-J, et al. The phenomenon of albumin-mediated hepatic uptake of organic anion transport polypeptide substrates: prediction of the in vivo uptake clearance from the in vitro uptake by isolated hepatocytes using a facilitated-dissociation model. Drug Metab Dispos. 2018;46(3):259–S4.
   PubMed Web of Science ®Google Scholar
• Sodhi JK, Liu S, Benet LZ. Challenging the Relevance of Unbound Tissue-to-Blood Partition Coefficient (Kpuu) on Prediction of Drug-Drug Interactions. Pharm Res. 2020;37(4):73.
   PubMed Web of Science ®Google Scholar
• Jones HM, Barton HA, Lai Y, et al. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos. 2012;40(5):1007–1017.
   PubMed Web of Science ®Google Scholar
• Li R, Barton HA, Yates PD, et al. A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling. J Pharmacokinet Pharmacodyn. 2014;41(3):197–209.
   PubMed Web of Science ®Google Scholar
• Liu H, Dong K, Zhang W, et al. Prediction of brain:blood unbound concentration ratios in CNS drug discovery employing in silico and in vitro model systems. Drug Discov Today. 2018;23(7):1357–1372.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen C. Free Drug Hypothesis for CNS Drug Candidates. In: Di L, Kerns EH, editors. Blood-Brain Barrier in Drug Discovery. Hoboken, New Jersey: John Wiley & Sons, Inc; 2015. p. 42–65.
   Google Scholar
• Wager TT, Hou X, Verhoest PR, et al. Moving beyond Rules: the Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties. ACS Chemical Neuroscience. 2010;1(6):435–449.
   PubMed Web of Science ®Google Scholar
• Knight ZA, Shokat KM. Features of Selective Kinase Inhibitors. Chemistry & Biology. 2005;12(6):621–637.
   PubMed Web of Science ®Google Scholar
• Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene. 2009;28(33):2925–2939.
   PubMed Web of Science ®Google Scholar
• Schwaid AG, Cornella-Taracido I. Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts. J Med Chem. 2018;61(5):1767–1773.
   PubMed Web of Science ®Google Scholar
• Vasta JD, Corona CR, Wilkinson J, et al. Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement. Cell Chemical Biology. 2018;25(2):206–214.e11.
   PubMed Web of Science ®Google Scholar